The forecast for the re-import of cortisone, hydrocortisone, prednisone, and prednisolone to Italy from 2024 to 2028 indicates a modest and consistent growth in value. Starting from $437.34k USD in 2024, the value is projected to rise slightly each year, reaching $439.07k USD by 2028, with an annual increase of approximately 0.33%. Given that 2023 values aren't available for direct comparison, the focus is on the subtle upward trend forecasted over the next five years, maintaining a stable growth trajectory.
Future trends to watch would include developments in healthcare policies affecting pharmaceutical imports and advancements in synthetic alternatives that could influence re-import dynamics. Monitoring these will provide greater insight into potential shifts in re-import patterns beyond 2028.
